(Q34211371)

31 July 2017

1 reference

title

Cell adhesion system and human cancer morphogenesis (English)

1 reference

31 July 2017

1 reference

1 reference

1

Setsuo Hirohashi

1 reference

31 July 2017

2

Yae Kanai

1 reference

31 July 2017

1 July 2003

1 reference

31 July 2017

1 reference

31 July 2017

94

1 reference

31 July 2017

575-581

1 reference

31 July 2017

7

1 reference

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

31 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Functional interaction of beta-catenin with the transcription factor LEF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Cloning of the human alpha-catenin cDNA and its aberrant mRNA in a human cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

E-cadherin gene mutations in signet ring cell carcinoma of the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

c-erbB-2 gene product associates with catenins in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

c-erbB-2 gene product directly associates with beta-catenin and plakoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Inactivation of the E-cadherin-mediated cell adhesion system in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Beta-catenin mutations in sporadic fundic gland polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Cloning and characterization of the human beta4-integrin gene promoter and enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

Prognostic significance of dysadherin expression in advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01485.X

10.1111/J.1349-7006.2003.TB01485.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12841864